The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 16, 2021
Filed:
Oct. 08, 2018
Merck Sharp & Dohme Corp., Rahway, NJ (US);
John Acton, Cranford, NJ (US);
David Annunziato Candito, Wrentham, MA (US);
J. Michael Ellis, Needham, MA (US);
Peter H. Fuller, Ashland, MA (US);
Hakan Gunaydin, Somerville, MA (US);
Blair T. Lapointe, Sudbury, MA (US);
Weiguo Liu, Princeton, NJ (US);
Joey L. Methot, Westwood, MA (US);
Santhosh F. Neelamkavil, Edison, NJ (US);
Barbara Pio, West Orange, NJ (US);
Vladimir Simov, South Boston, MA (US);
Harold B. Wood, Westfield, NJ (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
The present invention is directed to substituted certain reversed indazole compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein R, R, X, Y, Rand Rare as defined herein, which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease and other diseases and disorders described herein. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.